Category
Atenolol
CAS Number
35198-42-6
Molecular Formula
C₁₁H₁₁NO₂
Molecular Weight
189.2 g/mol
Synonym

2-[4-[[(2RS)-Oxiran-2-yl]methoxy]phenyl]acetonitrile ; 2-[4-(Oxiran-2-ylmethoxy)phenyl]acetonitrile;4-(2-Oxiranylmethoxy)benzeneacetonitrile ; 4-(2-Oxiranylmethoxy)benzeneacetonitrile

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Atenolol Cyano Epoxide (CAS No. 35198-42-6; Molecular Formula: C₁₁H₁₁NO₂; Molecular Weight: 224.3 g/mol) is a pharmaceutical impurity reference standard intended for atenolol impurity characterization, related substances testing, degradation product evaluation, chromatographic impurity profiling, analytical method development, and quality control testing. It can be used in HPLC and LC-MS/MS workflows for impurity detection, identification, quantification, stability-indicating analysis, and pharmaceutical analytical assessment.

Manasa Life Sciences is a trusted manufacturer and supplier of pharmaceutical impurity standards, API impurities, analytical reference materials, and specialty compounds in India. We provide custom impurity synthesis, structural characterization, purity assessment, forced degradation studies, stability evaluation, and analytical testing using HPLC, LC-MS/MS, NMR, FTIR, GC, qNMR, and TGA. Our products are supported by quality documentation such as COA and MSDS/SDS and help pharmaceutical manufacturers and analytical laboratories address applicable ICH, EMA, European Pharmacopoeia (EP), and United States Pharmacopeia (USP) expectations for impurity control, analytical quality, and regulatory compliance.